IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,316 | +13.5% | 12,713 | +21.5% | 0.00% | – |
| Q2 2023 | $108,679 | -1.2% | 10,460 | 0.0% | 0.00% | – |
| Q1 2023 | $110,039 | -15.1% | 10,460 | 0.0% | 0.00% | – |
| Q4 2022 | $129,600 | -75.1% | 10,460 | -77.1% | 0.00% | -100.0% |
| Q4 2020 | $520,000 | -38.7% | 45,622 | -51.6% | 0.00% | -50.0% |
| Q3 2020 | $848,000 | +12.9% | 94,316 | +29.6% | 0.00% | 0.0% |
| Q2 2020 | $751,000 | +1.8% | 72,766 | -0.5% | 0.00% | 0.0% |
| Q1 2020 | $738,000 | +1.7% | 73,110 | +34.0% | 0.00% | 0.0% |
| Q4 2019 | $726,000 | -35.5% | 54,540 | -40.3% | 0.00% | -66.7% |
| Q1 2014 | $1,125,000 | +121.9% | 91,322 | +109.0% | 0.01% | +100.0% |
| Q4 2013 | $507,000 | -1.9% | 43,685 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $517,000 | +19.7% | 43,685 | +0.5% | 0.00% | +50.0% |
| Q2 2013 | $432,000 | – | 43,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |